NDC 72189-129
Losartan Potassium And Hydrochlorothiazide 50 mg / 12.5 mg tablet, film coated
On the label: Direct Rx. It's repackaged: Direct Rx rebottles it from Jubilant Cadista Pharmaceuticals Inc.'s NDC 59746-337.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| The ACME Laboratories Ltd. | Dhaka, Bangladesh | Makes it | Not inspected on record |
Repackaging site
- Direct Rx, Dawsonville, GA, United States · repackages it
Recalls
- May 5, 2022 · Class II · Direct Rx
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Lots: a) 30-count bottles- Lot: 11MY2103 Exp. 11/30/22 Lot: 05JA2106 Exp. 6/30/22 b) 90-count bottles- Lot: 20MY2115 Exp. 11/30/22 Lot: 22JU2118 Exp. 12/31/22 Lot: 29JY2113 Exp. 12/31/22 Lot: 13SE2113 Exp. 2/28/23 Lot: 05JA2106 Exp. 6/30/22 - Jul 11, 2014 · Class II · Jubilant Cadista Pharmaceuticals Inc.
Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Lots: Lot #14P0292, Exp 04/2016
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Hydrochlorothiazide and Losartan: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 50 mg / 12.5 mg
- Approval
- ANDA ANDA201845
- On the market since
- Oct 15, 2020
- Package NDCs
72189-129-3072189-129-90- Official label
- DailyMed (National Library of Medicine), updated Jan 17, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?